Clinical Trials Logo

Revision clinical trials

View clinical trials related to Revision.

Filter by:
  • None
  • Page 1

NCT ID: NCT05002959 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

TESS V3 Modular Total Shoulder System PMCF

Start date: February 1, 2022
Phase:
Study type: Observational

This is a multicenter, retrospective and prospective, non-controlled post market surveillance study. The objectives of this study are to confirm safety, performance and clinical benefits of the T.E.S.S.® Version 3 Anatomic and Reverse Modular Total shoulder prosthesis and its instrumentation.

NCT ID: NCT03431857 Completed - Clinical trials for Rheumatoid Arthritis

Multi Centre Study on TESS V2 Shoulder System

Start date: October 20, 2010
Phase:
Study type: Observational

This study is a Post Market Clinical Follow-up study to fulfill the post market surveillance requirements. The data collected from this study will serve the purpose of confirming safety and performance of the TESS Shoulder System.

NCT ID: NCT03423953 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

Comprehensive Nano - Post Market Clinical Follow-Up Study

Start date: October 30, 2013
Phase:
Study type: Observational

This data collection project is intended to provide clinical outcomes data to engineering, marketing as well as fulfill the post market surveillance requirements of various regulatory authorities. The study will be a prospective and one-arm.

NCT ID: NCT02865928 Terminated - Augmentation Clinical Trials

Serratus Plane Block for Postoperative Pain Control

Start date: September 5, 2017
Phase: Phase 4
Study type: Interventional

This is a randomized, double-blinded, placebo-controlled trial of serratus plane blocks in subjects undergoing outpatient unilateral or bilateral breast surgery. Ninety subjects will be enrolled into the study at presurgical testing. Subjects will be stratified based on surgery type and randomized to receive a serratus plane block with either bupivicaine HCL or placebo. All patients will receive standard intraoperative anesthesia and standard postoperative pain control. The primary endpoint is the amount of opioid administered postoperatively. Secondary endpoints include postoperative pain intensity at timed intervals, amount of opioid administered intraoperatively and postoperatively, incidence of nausea and vomiting, time to discharge and patient satisfaction